tirzepatide march 2025 FDA Says Compounded Must Exit the Market March 19, 2025 Important Update:

Tirzepatide is a dual GLP-1 and GIP receptor agonist that requires consistent weekly injection timing to maximize metabolic benefits

This interaction is present between methylprednisolone and grapefruit juice, with studies demonstrating that high amounts of grapefruit juice increase blood levels of methylprednisolone

Semaglutide, by contrast, comes as a once-weekly injection that bypasses the gastrointestinal absorption pathway entirely, eliminating any competition for intestinal uptake

Exercise and Strength Training for Long-Term Weight Stability Cardiovascular exercise burns calories, but resistance training preserves muscle mass and boosts resting metabolic rateyour calorie-burning engine at rest

Weight trajectories, metabolic markers, and subjective wellbeing measurements provide optimization guidance

HSA and FSA funds are eligible, and no membership fees apply